Skip to main content

and
  1. Article

    Open Access

    Prognostic value of the tumor-to-liver density ratio in patients with metastatic colorectal cancer treated with bevacizumab-based chemotherapy. A post-hoc study of the STIC-AVASTIN trial

    The Response Evaluation Criteria in Solid Tumors (RECIST) are often inadequate for the early assessment of the response to cancer therapy, particularly bevacizumab-based chemotherapy. In a first cohort of pati...

    Thibault Mazard, Caroline Mollevi, Evelyne M. Loyer, Julie Léger in Cancer Imaging (2024)